BioStock: Miris reports Q3 sales growth

Medtech company Miris reports sales growth for Q3, continuing the positive trend from the first half of the year. Sales increased by as much as 133 per cent and the company is well on its way to profitability as the net loss was halved compared to the same quarter 2021. Miris’ CEO Camilla Myhre Sandberg commented on the report and talked about the prospects for the company’s market-approved instruments for analysing breast milk.

Read the interview with Miris' CEO Camilla Myhre Sandberg at biostock.se:

https://www.biostock.se/en/2022/11/miris-reports-q3-sales-growth/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se